Brief: Enorama Pharma Q2 Oper Loss Narrows To SEK 1.8 Mln
12/08/2020 07:37
Aug 12 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q2 NET SALES SEK 4.5 MILLION VERSUS SEK 4.2 MILLION YEAR
AGO
* Q2 OPERATING LOSS SEK 1.8 MILLION VERSUS LOSS SEK 4.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1ycMNf
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO